French company DBV-Technologies is set to make waves in the world of immunotherapy, with its revolutionary research into allergy patches.
Allergies have probably never been more prominent in the public consciousness than they are now. Well-known allergies range from everyday products like egg to the more exotic crabmeat.
DBV Technologies is seemingly well on the way to finding an EPIT-based solution to allergies – more information is available on http://www.dbv-technologies.com/en/epit.
As the name suggests, this epicutaneous patch is applied to the skin. The primary components of the patch revolve around its metal backing (PET titanium), breathable over-adhesive and adhesive crown.
The strategy behind the Viaskin patch isn’t particularly complicated. Tiny amounts of the relevant allergen are sprayed upon the patch in an even coating, which then dries.An ultra-moisturizing ‘condensation chamber’ formed between patch and skin allows these protein compounds to reach the tolerogenic Langerhans cells, where they begin the work of gradually desensitizing the body to these antigens.
Those with loved ones suffering from a peanut allergy should look at the dedicated page: http://www.dbv-technologies.com/en/viaskin-products/Viaskin-peanut .